Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Lilly (Eli) (LLY)

Eli Lilly elects Carolyn Bertozzi, Stanford chemist, to its board effective Dec. 8, 2025

Neutral Impact 2 of 5 leadership Written later

Eli Lilly's board elected Stanford University chemistry professor Carolyn R. Bertozzi as a new director, effective December 8, 2025. She will serve on the Science and Technology Committee and the Ethics and Compliance Committee, and must stand for shareholder election at the May 2026 annual meeting.

Key points

  • Board elected Dr. Carolyn R. Bertozzi, age 59, on November 18, 2025, effective December 8, 2025
  • Board determined she is independent under NYSE standards and company guidelines
  • She joins the Science and Technology Committee and the Ethics and Compliance Committee
  • Shareholders will vote on her election at the May 2026 annual meeting

The filing

CompanyLilly (Eli) (LLY)
Form8-K, current report
Filed with the SECNov 21, 2025, 4:19 PM ET
Accession number0000059478-25-000271

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 21, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.